Mirion Technologies, Inc. (NYSE: MIR), a global leader in radiation detection, measurement, analysis, and monitoring solutions for the medical, nuclear, defense, and research sectors, today announced the pricing of an underwritten public offering of 7,000,000 shares of its Class A common stock by certain selling stockholders at a price to the public of $7.65 per share.
Participating in the offering are entities affiliated with Charterhouse Capital Partners. Mirion will bear the costs associated with the public offering, excluding underwriting discounts and commissions and certain other expenses. The offering is expected to close on May 16, 2023, pending customary closing conditions.
Citigroup is taking the reins as the sole bookrunner for this exciting offering! They are ready to make the most of this opportunity and ensure a successful outcome.
The Securities and Exchange Commission (SEC) has declared a shelf registration statement, including a base prospectus, effective as of November 28, 2022, allowing Mirion to offer its securities. Before you invest, take a moment to read the prospectus in the registration statement and other documents Mirion has filed or will file with the SEC.
To obtain free copies of the prospectus supplement and accompanying prospectus related to the offering, visit the SEC’s website. Alternatively, you can contact Citigroup, c/o Broadridge Financial Solutions, at 1155 Long Island Avenue, Edgewood, NY 11717 (Tel: 800-831-9146). Take the time to get informed about Mirion and this offering!
We are pleased to announce an exciting investment opportunity! Our offering of these securities is a chance for you to expand your portfolio and potentially benefit from the potential of these securities. However, before taking part in this offering, please note that it must be registered or qualified under the securities laws of the relevant state or jurisdiction. Don’t miss out on this great opportunity!